Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Signal 0 for guided priming of CTLs: NKT cells do it too.

Bousso P, Albert ML.

Nat Immunol. 2010 Apr;11(4):284-6. doi: 10.1038/ni0410-284. Review. No abstract available.


Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, Panzer U, Rossjohn J, Perlmutter P, Cao J, Godfrey DI, Savage PB, Knolle PA, Kolanus W, Förster I, Kurts C.

Nat Immunol. 2010 Apr;11(4):313-20. doi: 10.1038/ni.1848.


Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.

Osmond TL, Farrand KJ, Painter GF, Ruedl C, Petersen TR, Hermans IF.

J Immunol. 2015 Aug 1;195(3):821-31. doi: 10.4049/jimmunol.1401751.


Cross-dressing: an alternative mechanism for antigen presentation.

Campana S, De Pasquale C, Carrega P, Ferlazzo G, Bonaccorsi I.

Immunol Lett. 2015 Dec;168(2):349-54. doi: 10.1016/j.imlet.2015.11.002. Review.


NKT cells: T lymphocytes with innate effector functions.

Van Kaer L.

Curr Opin Immunol. 2007 Jun;19(3):354-64. Review.


Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljeström P, Reis e Sousa C.

Nature. 2005 Feb 24;433(7028):887-92.


The NK/DC complot.

Marcenaro E, Della Chiesa M, Pesce S, Agaugué S, Moretta A.

Adv Exp Med Biol. 2009;633:7-16. Review. No abstract available.


How to connect an IgE-driven response with CTL activity?

Platzer B, Dehlink E, Turley SJ, Fiebiger E.

Cancer Immunol Immunother. 2012 Sep;61(9):1521-5. doi: 10.1007/s00262-011-1127-y.


Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.

Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML.

Cell Death Differ. 2009 Jul;16(7):991-1005. doi: 10.1038/cdd.2009.8.


Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.

van Montfoort N, Camps MG, Khan S, Filippov DV, Weterings JJ, Griffith JM, Geuze HJ, van Hall T, Verbeek JS, Melief CJ, Ossendorp F.

Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6730-5. doi: 10.1073/pnas.0900969106.


Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.

Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF.

J Immunol. 2009 Dec 15;183(12):7732-42. doi: 10.4049/jimmunol.0902707.


A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Hunzeker JT, Elftman MD, Mellinger JC, Princiotta MF, Bonneau RH, Truckenmiller ME, Norbury CC.

J Immunol. 2011 Jan 1;186(1):183-94. doi: 10.4049/jimmunol.1001737.


Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Macho-Fernandez E, Cruz LJ, Ghinnagow R, Fontaine J, Bialecki E, Frisch B, Trottein F, Faveeuw C.

J Immunol. 2014 Jul 15;193(2):961-9. doi: 10.4049/jimmunol.1303029.


Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.

Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, Barr IG, Doherty PC, Godfrey DI, Turner SJ.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3330-5. doi: 10.1073/pnas.0813309106.


HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.

Chauvin JM, Larrieu P, Sarrabayrouse G, Prévost-Blondel A, Lengagne R, Desfrançois J, Labarrière N, Jotereau F.

J Immunol. 2012 Mar 1;188(5):2102-10. doi: 10.4049/jimmunol.1101807.


Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells.

Shimizu K, Mizuno T, Shinga J, Asakura M, Kakimi K, Ishii Y, Masuda K, Maeda T, Sugahara H, Sato Y, Matsushita H, Nishida K, Hanada K, Dorrie J, Schaft N, Bickham K, Koike H, Ando T, Nagai R, Fujii S.

Cancer Res. 2013 Jan 1;73(1):62-73. doi: 10.1158/0008-5472.CAN-12-0759.


Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.

Rzemieniak SE, Hirschfeld AF, Victor RE, Chilvers MA, Zheng D, van den Elzen P, Turvey SE.

Immunology. 2010 Jun;130(2):288-95. doi: 10.1111/j.1365-2567.2009.03234.x.

Supplemental Content

Support Center